Phase I Study of INCB039110 in Combination With Dabrafenib and Trametinib in Patients With BRAF-mutant Melanoma and Other Solid Tumors.
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 18 May 2018
At a glance
- Drugs Itacitinib (Primary) ; Dabrafenib; Trametinib
- Indications Malignant melanoma; Solid tumours
- Focus Adverse reactions
- 06 Mar 2018 Planned initiation date changed from 30 Sep 2017 to 30 Jul 2018.
- 07 Sep 2017 New trial record